Home › NDC Lookup › RxCUI directory › RxCUI 2688947

250 ML dibasic potassium phosphate 4.72 MG/ML / monobasic potassium phosphate 4.48 MG/ML I... — RxCUI 2688947

Name: 250 ML dibasic potassium phosphate 4.72 MG/ML / monobasic potassium phosphate 4.48 MG… (RxCUI 2688947)
Creator: Brian Staiger, PharmD

RxNorm drug concept · Semantic clinical drug

RxCUI 2688947 Semantic clinical drug · SCD ● Current RxNorm concept 3 FDA products 3 package NDCs Snapshot Jul 14, 2026

This page is curated, coded, and maintained by Dr. Brian Staiger, PharmD

Compiled from public NLM RxNorm and FDA (openFDA NDC directory) data sources. Editorial policy

What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.

🗂️ Key Facts

RxCUI2688947

Official name250 ML dibasic potassium phosphate 4.72 MG/ML / monobasic potassium phosphate 4.48 MG/ML Injection

Concept typeSemantic clinical drug (SCD)

RxNorm statusCurrent RxNorm concept

Also known asphosphorus 15 MMOL / potassium 22 MEQ per 250 ML Injection; potassium phosphates (phosphorus 15 MMOL / potassium 22 MEQ) in 250 ML Injection; 250 ML dibasic K+ phosphate 4.72 MG/ML / monobasic K+ phosphate 4.48 MG/ML Injection; 250 ML dibasic Pot phosphate 4.72 MG/ML / monobasic Pot phosphate 4.48 MG/ML Injection

FDA products mapped3

Package NDCs mapped3

RxNorm release07/06/2026

Snapshot dataJul 14, 2026

📖 Skip the Codes — Read It in Plain English.

Our pharmacist-built guide to Potassium Phosphates: what it is, how it’s used, side effects, and interactions.

📗 Our plain-language guide HelloPharmacist

Great question. This IV form is used when your phosphate levels are too low to safely wait for a pill to work, or when you're not able to eat or take anything by mouth right now. I...
Why am I getting this through an IV instead of just taking a phosphorus pill?
It depends on how serious your kidney issues are. If you have severe kidney disease or are on dialysis, this specific product cannot be used — your kidneys would struggle to clear...
Is it safe to get this if I have kidney problems?

📖 Read our full Potassium Phosphates guide →

🕸️ Concept Web — How 250 ML dibasic potassium phosphate 4.72 MG/ML /... Connects

One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.

This page's concept 250 ML dibasic potassium phosphate 4.72 MG/ML / monobasic potassium phosphate 4.48 MG/ML Injection RxCUI 2688947 Semantic clinical drug · SCD

Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.

Ingredients 4

The active substance itself — no strength, form, or brand attached yet.
- Dibasic potassium phosphate 55018 IN
- Potassium phosphate 34322 IN
- Dibasic potassium phosphate / potassium phosphate 1008224 MIN
- Monobasic potassium phosphate 55019 PIN
Dose forms 6

The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.
- Dibasic potassium phosphate / potassium phosphate Injection 1928566 SCDF
- Dibasic potassium phosphate / monobasic potassium phosphate Injection 2649367 SCDFP
- Dibasic potassium phosphate / potassium phosphate Injectable Product 1155876 SCDG
- Dibasic potassium phosphate / monobasic potassium phosphate Injectable Product 2663146 SCDGP
- Injection 1649574 DF
- Injectable Product 1151126 DFG
Clinical & branded drugs 2

Ingredient + strength + dose form. These are the concepts real FDA products actually carry.
- Dibasic potassium phosphate 4.72 MG/ML 2688945 SCDC
- Monobasic potassium phosphate 4.48 MG/ML 2688946 SCDC

Showing up to 8 concepts per family — 12 of 12 stored related concepts drawn.

These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.

🔀 Generic ⇄ Brand Crosswalk

The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.

Generic (Clinical) Concepts

Dibasic potassium phosphate 4.72 MG/ML SCDC · 2688945
Monobasic potassium phosphate 4.48 MG/ML SCDC · 2688946
Dibasic potassium phosphate / potassium phosphate Injection SCDF · 1928566
Dibasic potassium phosphate / monobasic potassium phosphate Injection SCDFP · 2649367
Dibasic potassium phosphate / potassium phosphate Injectable Product SCDG · 1155876
Dibasic potassium phosphate / monobasic potassium phosphate Injectable Product SCDGP · 2663146

📦 FDA Products & Package NDCs

3 products · 3 package NDCs

3 package NDCs map to RxCUI 2688947 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.

Package NDC	Package	Brand / generic name	Labeler	Marketing start
65219-0656-10	24 POUCH in 1 CARTON (65219-656-10) / 1 BAG in 1 POUCH (652...	Potassium Phosphates	Fresenius Kabi USA, LLC	2025-06-15
65219-0658-25	30 POUCH in 1 CARTON (65219-658-25) / 1 BAG in 1 POUCH (652...	Potassium Phosphates	Fresenius Kabi USA, LLC	2025-06-15
70121-1722-09	24 POUCH in 1 CARTON (70121-1722-9) / 1 BAG in 1 POUCH / 25...	POTASSIUM PHOSPHATES	Amneal Pharmaceuticals LLC	2024-07-30

Observed labelers: Fresenius Kabi USA, LLC (2) · Amneal Pharmaceuticals LLC (1) — this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.

🗃️ Sources & Limits

Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7

openFDA export observedJul 14, 2026

RxNorm release07/06/2026

Methodology2026-07-full-catalog-v1

A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.

This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.

Machine-readable JSON

Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.